Literature DB >> 28457351

Rift Valley Fever.

Amy Hartman1.   

Abstract

Rift Valley fever (RVF) is a severe veterinary disease of livestock that also causes moderate to severe illness in people. The life cycle of RVF is complex and involves mosquitoes, livestock, people, and the environment. RVF virus is transmitted from either mosquitoes or farm animals to humans, but is generally not transmitted from person to person. People can develop different diseases after infection, including febrile illness, ocular disease, hemorrhagic fever, or encephalitis. There is a significant risk for emergence of RVF into new locations, which would affect human health and livestock industries.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Mosquitos; Rift Valley fever; Transmission; Treatment

Mesh:

Substances:

Year:  2017        PMID: 28457351      PMCID: PMC5458783          DOI: 10.1016/j.cll.2017.01.004

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  82 in total

1.  Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, 2007.

Authors:  Mohamed Mohamed; Fausta Mosha; Janeth Mghamba; Sherif R Zaki; Wun-Ju Shieh; Janusz Paweska; Sylvia Omulo; Solomon Gikundi; Peter Mmbuji; Peter Bloland; Nordin Zeidner; Raphael Kalinga; Robert F Breiman; M Kariuki Njenga
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

2.  Risk assessment of the introduction of Rift Valley fever from the Horn of Africa to Yemen via legal trade of small ruminants.

Authors:  Shaif Abdo-Salem; Agnès Waret-Szkuta; François Roger; Marie-Marie Olive; Khalid Saeed; Véronique Chevalier
Journal:  Trop Anim Health Prod       Date:  2010-10-22       Impact factor: 1.559

3.  Unfilled Vials.

Authors:  Jon Cohen
Journal:  Science       Date:  2016-01-01       Impact factor: 47.728

4.  Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle.

Authors:  J C Morrill; C A Mebus; C J Peters
Journal:  Am J Vet Res       Date:  1997-10       Impact factor: 1.156

Review 5.  One Health approach to Rift Valley fever vaccine development.

Authors:  Jeroen Kortekaas
Journal:  Antiviral Res       Date:  2014-03-26       Impact factor: 5.970

6.  Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans.

Authors:  Phillip R Pittman; David McClain; Xiaofei Quinn; Kevin M Coonan; Joseph Mangiafico; Richard S Makuch; John Morrill; Clarence J Peters
Journal:  Vaccine       Date:  2015-12-22       Impact factor: 3.641

7.  Rift Valley fever and a new paradigm of research and development for zoonotic disease control.

Authors:  Osman Dar; Sabrina McIntyre; Sue Hogarth; David Heymann
Journal:  Emerg Infect Dis       Date:  2013-02       Impact factor: 6.883

8.  RIFT VALLEY FEVER : A REPORT OF THREE CASES OF LABORATORY INFECTION AND THE EXPERIMENTAL TRANSMISSION OF THE DISEASE TO FERRETS.

Authors:  T Francis; T P Magill
Journal:  J Exp Med       Date:  1935-08-31       Impact factor: 14.307

9.  Factors associated with severe human Rift Valley fever in Sangailu, Garissa County, Kenya.

Authors:  A Desirée LaBeaud; Sarah Pfeil; Samuel Muiruri; Saidi Dahir; Laura J Sutherland; Zachary Traylor; Ginny Gildengorin; Eric M Muchiri; John Morrill; C J Peters; Amy G Hise; James W Kazura; Charles H King
Journal:  PLoS Negl Trop Dis       Date:  2015-03-12

10.  Potency of a thermostabilised chimpanzee adenovirus Rift Valley Fever vaccine in cattle.

Authors:  Pawan Dulal; Daniel Wright; Rebecca Ashfield; Adrian V S Hill; Bryan Charleston; George M Warimwe
Journal:  Vaccine       Date:  2016-03-25       Impact factor: 3.641

View more
  30 in total

1.  A protective bivalent vaccine against Rift Valley fever and bluetongue.

Authors:  Eva Calvo-Pinilla; Alejandro Marín-López; Sandra Moreno; Gema Lorenzo; Sergio Utrilla-Trigo; Luis Jiménez-Cabello; Julio Benavides; Aitor Nogales; Rafael Blasco; Alejandro Brun; Javier Ortego
Journal:  NPJ Vaccines       Date:  2020-07-30       Impact factor: 7.344

2.  Reagents for detection of Rift Valley fever virus infection in sheep.

Authors:  Brian J Shiell; Siying Ye; Jennifer A Harper; Brenda van der Heide; Gary Beddome; Adam J Foord; Wojtek P Michalski; John Bingham; Grantley R Peck
Journal:  J Vet Diagn Invest       Date:  2020-05-25       Impact factor: 1.279

3.  Structural Elucidation of Rift Valley Fever Virus L Protein towards the Discovery of Its Potential Inhibitors.

Authors:  Mubarak A Alamri; Muhammad Usman Mirza; Muhammad Muzammal Adeel; Usman Ali Ashfaq; Muhammad Tahir Ul Qamar; Farah Shahid; Sajjad Ahmad; Eid A Alatawi; Ghadah M Albalawi; Khaled S Allemailem; Ahmad Almatroudi
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-25

4.  EGR1 Upregulation during Encephalitic Viral Infections Contributes to Inflammation and Cell Death.

Authors:  Caitlin W Lehman; Amy Smith; Jamie Kelly; Jonathan L Jacobs; Jonathan D Dinman; Kylene Kehn-Hall
Journal:  Viruses       Date:  2022-06-02       Impact factor: 5.818

Review 5.  Rift Valley fever: biology and epidemiology.

Authors:  Daniel Wright; Jeroen Kortekaas; Thomas A Bowden; George M Warimwe
Journal:  J Gen Virol       Date:  2019-07-16       Impact factor: 5.141

6.  NSs amyloid formation is associated with the virulence of Rift Valley fever virus in mice.

Authors:  Psylvia Léger; Eliana Nachman; Karsten Richter; Carole Tamietti; Jana Koch; Robin Burk; Susann Kummer; Qilin Xin; Megan Stanifer; Michèle Bouloy; Steeve Boulant; Hans-Georg Kräusslich; Xavier Montagutelli; Marie Flamand; Carmen Nussbaum-Krammer; Pierre-Yves Lozach
Journal:  Nat Commun       Date:  2020-07-01       Impact factor: 14.919

7.  Identification of Bunyamwera and Possible Other Orthobunyavirus Infections and Disease in Cattle during a Rift Valley Fever Outbreak in Rwanda in 2018.

Authors:  Marie Fausta Dutuze; Angelique Ingabire; Isidore Gafarasi; Solange Uwituze; Manassé Nzayirambaho; Rebecca C Christofferson
Journal:  Am J Trop Med Hyg       Date:  2020-04-16       Impact factor: 2.345

8.  Pathogenesis of Rift Valley Fever Virus Aerosol Infection in STAT2 Knockout Hamsters.

Authors:  Brady T Hickerson; Jonna B Westover; Arnaud J Van Wettere; Johanna D Rigas; Jinxin Miao; Bettina L Conrad; Neil E Motter; Zhongde Wang; Brian B Gowen
Journal:  Viruses       Date:  2018-11-19       Impact factor: 5.048

9.  First Serological Evidence of Crimean-Congo Hemorrhagic Fever Virus and Rift Valley Fever Virus in Ruminants in Tunisia.

Authors:  Khaoula Zouaghi; Ali Bouattour; Hajer Aounallah; Rebecca Surtees; Eva Krause; Janine Michel; Aymen Mamlouk; Andreas Nitsche; Youmna M'ghirbi
Journal:  Pathogens       Date:  2021-06-18

10.  A protective bivalent vaccine against Rift Valley fever and bluetongue.

Authors:  Eva Calvo-Pinilla; Alejandro Marín-López; Sandra Moreno; Gema Lorenzo; Sergio Utrilla-Trigo; Luis Jiménez-Cabello; Julio Benavides; Aitor Nogales; Rafael Blasco; Alejandro Brun; Javier Ortego
Journal:  NPJ Vaccines       Date:  2020-07-30       Impact factor: 7.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.